Canada markets closed

Emergent BioSolutions Inc. (EBS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
4.3500-0.0200 (-0.46%)
At close: 04:00PM EDT
4.4000 +0.05 (+1.15%)
After hours: 07:55PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 227.95M
Enterprise Value 1.06B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.19
Price/Book (mrq)0.34
Enterprise Value/Revenue 2.23
Enterprise Value/EBITDA 6.87

Trading Information

Stock Price History

Beta (5Y Monthly) 1.24
52-Week Change 3-53.18%
S&P500 52-Week Change 326.27%
52 Week High 39.9600
52 Week Low 31.4200
50-Day Moving Average 32.6060
200-Day Moving Average 32.9451

Share Statistics

Avg Vol (3 month) 36.06M
Avg Vol (10 day) 320.19M
Shares Outstanding 552.4M
Implied Shares Outstanding 652.4M
Float 851.7M
% Held by Insiders 11.88%
% Held by Institutions 175.63%
Shares Short (Apr 30, 2024) 47.13M
Short Ratio (Apr 30, 2024) 47.01
Short % of Float (Apr 30, 2024) 416.65%
Short % of Shares Outstanding (Apr 30, 2024) 413.61%
Shares Short (prior month Mar 28, 2024) 45.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -47.69%
Operating Margin (ttm)13.25%

Management Effectiveness

Return on Assets (ttm)-0.38%
Return on Equity (ttm)-60.57%

Income Statement

Revenue (ttm)1.19B
Revenue Per Share (ttm)22.93
Quarterly Revenue Growth (yoy)82.80%
Gross Profit (ttm)N/A
EBITDA 100.2M
Net Income Avi to Common (ttm)-565.3M
Diluted EPS (ttm)-10.9700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)78.5M
Total Cash Per Share (mrq)1.5
Total Debt (mrq)922.2M
Total Debt/Equity (mrq)138.91%
Current Ratio (mrq)1.08
Book Value Per Share (mrq)12.67

Cash Flow Statement

Operating Cash Flow (ttm)-84.9M
Levered Free Cash Flow (ttm)133.66M